Medical Professional Publications

Pharmacy and Therapeutics Committee Updates

(From the April 2014 Issue of MedStat)

For more detailed information, contact Kimberly Novak at

The following actions were taken at the March 6 Pharmacy & Therapeutics Committee meeting.

Revisionsto the Ethanol Lock Guidelines for Use and PFC XI-40:16 Central Venous Catheter: Ethanol Lock Therapy were APPROVED. Dr. Balint presented data and practice experience with concomitant metronidazole and ethanol lock therapy in patients with intestinal failure. Concomitant use of metronidazole with ethanol lock therapy will now be allowed. The updated guidelines have been posted on the P&T intranet website and the Epic link will be fixed soon. The updated Patient Family Care (PFC) policy will be presented at the next PFC meeting and will be posted on the policy website afterwards.

Medication Stock Lists were APPROVED for the following clinics: Sharon Woods Primary Care, Plastics Clinic Parsons Ave, and Eye Clinic.

Menveo® (meningococcal groups A, C, Y and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine (MCV4-CRM) was APPROVED for formulary addition. This vaccine will facilitate concomitant pneumococcal vaccination in patients as young as 2 months of age. The monograph will be posted on P&T intranet website. A review of formulary drug use will be presented in six months.

Menomune® (meningococcal groups A, C, Y and W-135 polysaccharide vaccine) was REMOVED from formulary.

Malarone® (atovoquone and proguanil) was APPROVED for formulary addition for treatment and prophylaxis of malaria. The monograph will be posted on the P&T intranet website. A review of formulary drug use will be presented in six months.

For informational purposes:

The Gadolinium (Magnevist®) Based Contrast MRI (GBCM) Premedication and Treatment Protocol was presented but sent back for clarification/revision. It will be re-presented at a later date.

A medication use evaluation follow-up report was presented on compliance with discharge documentation on home-going inpatient inhalers. Appropriate documentation of patient/family receipt of inpatient inhalers was present in 14% of charts in July 2013 and 25% of charts in August 2013. After re-education, audits of selected charts in September 2013 through January 2014 revealed 41% compliance (range 36 to 48%). Re-education of residents and unit nurses is ongoing. Additional education will be distributed to APNs, and ongoing audits will continue.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000